According to Grand View Research, the European and Middle Eastern drug screening markets are projected to grow significantly by 2030, with Europe expected to reach $3.6 billion 1 and the Middle East ...
Intelligent Bio Solutions (INBS) announced the strengthening of its foothold throughout Europe and the Middle East through its partnership with ...
The global hepatitis diagnostic test market is poised for significant growth, with market value projected to increase from USD 3621.5 million in 2024 to USD 6118.4 million by 2033, reflecting a steady ...